GRAM publications
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.
Antimicrobial Resistance Collaborators None., (2022), Lancet, 399, 629 - 655
Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019.
GBD 2019 Antimicrobial Resistance Collaborators None., (2022), Lancet, 400, 2221 - 2248
The burden of bacterial antimicrobial resistance in the WHO European region in 2019: a cross-country systematic analysis.
European Antimicrobial Resistance Collaborators None., (2022), Lancet Public Health, 7, e897 - e913
Mapping local variation in household overcrowding across Africa from 2000 to 2018: a modelling study.
Chipeta MG. et al, (2022), Lancet Planet Health, 6, e670 - e681
Global antibiotic consumption and usage in humans, 2000-18: a spatial modelling study.
Browne AJ. et al, (2021), Lancet Planet Health
The challenges of estimating the human global burden of disease of antimicrobial resistant bacteria.
Dunachie SJ. et al, (2020), Curr Opin Microbiol, 57, 95 - 101
Drug-resistant enteric fever worldwide, 1990 to 2018: a systematic review and meta-analysis.
Browne AJ. et al, (2020), BMC Med, 18
Measuring and mapping the global burden of antimicrobial resistance.
Hay SI. et al, (2018), BMC Med, 16
Drug-resistant bacterial infections: We need urgent action and investment that focus on the weakest link.
Dolecek C. et al, (2022), PLoS Biol, 20
Recent publications by Researchers affiliated with the GRAM project
Southeast Asia initiative to combat SARS-CoV-2 variants (SEACOVARIANTS) consortium
Nhu LNT. et al, (2024), Wellcome Open Research, 9, 181 - 181
Understanding hospital antimicrobial prescribing decisions and determinants of uptake of new local antimicrobial prescribing guidelines in the Laos
Chansamouth V. et al, (2024), Wellcome Open Research, 9, 183 - 183
Estimating the subnational prevalence of antimicrobial resistant Salmonella enterica serovars Typhi and Paratyphi A infections in 75 endemic countries, 1990-2019: a modelling study.
GRAM Typhoid Collaborators None., (2024), Lancet Glob Health, 12, e406 - e418
Primaquine in glucose-6-phosphate dehydrogenase deficiency: an adaptive pharmacometric assessment of ascending dose regimens in healthy volunteers.
Pukrittayakamee S. et al, (2024), Elife, 12
Statin Use and Reduced Risk of Pneumonia in Melioidosis Patients: A Lung-Specific Statin Association.
Coston TD. et al, (2023), Ann Am Thorac Soc
Plasma Metabolomics Reveals Distinct Biological and Diagnostic Signatures for Melioidosis.
Xia L. et al, (2023), Am J Respir Crit Care Med
Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial.
Schilling WHK. et al, (2023), Lancet Infect Dis
Geographical distribution of scrub typhus and risk of Orientia tsutsugamushi infection in Indonesia: Evidence mapping.
Saraswati K. et al, (2023), PLoS Negl Trop Dis, 17
BurkHostGEN: a study protocol for evaluating variations in the Burkholderia pseudomallei and host genomes associated with melioidosis infection
Angchagun K. et al, (2023), Wellcome Open Research, 8, 347 - 347
Urinary catecholamine excretion, cardiovascular variability, and outcomes in tetanus.
Du DH. et al, (2023), Trop Med Health, 51
Lineage-informative microhaplotypes for spatio-temporal surveillance of Plasmodium vivax malaria parasites.
Siegel SV. et al, (2023), medRxiv
Intravenous Doxycycline, Azithromycin, or Both for Severe Scrub Typhus.
Varghese GM. et al, (2023), N Engl J Med, 388, 792 - 803
Pharmacometrics of high dose ivermectin in early COVID-19: an open label, randomized, controlled adaptive platform trial (PLATCOV)
Schilling WHK. et al, (2023), eLife, 12
Characteristics and One Year Outcomes of Melioidosis Patients in Northeastern Thailand: A Prospective, Multicenter Cohort Study.
Chantratita N. et al, (2023), Lancet Reg Health Southeast Asia, 9
BurkHostGEN: a study protocol for evaluating variations in the Burkholderia pseudomallei and host genomes associated with melioidosis infection.
Angchagun K. et al, (2023), Wellcome Open Res, 8
Pf7: an open dataset of Plasmodium falciparum genome variation in 20,000 worldwide samples.
MalariaGEN None. et al, (2023), Wellcome open research, 8
Pf7: an open dataset of Plasmodium falciparum genome variation in 20,000 worldwide samples.
MalariaGEN None. et al, (2023), Wellcome Open Res, 8